Post-HCT outcomes for 810 adults with AML undergoing allogeneic HCT while in first or second morphologic remission, stratified by early peri-HCT MRD dynamics and conditioning intensity. Risk of relapse and OS are shown separately for patients with HCT on the MAC (n = 463; A-B) and non-MAC (n = 317; C-D) regimens.